中文
Reagents:
Molecular Biology
Biochemistry
Cell Biology
ELISA / Diagnostic Kits
Antibody
Serum/Medium
Other Reagents
- Best antibody pairs HBeAg HBeAb for your HBV test reagent
- Product Detail
- Company Profile
Chinese NO1 market share antibody HBeAg from AokeBotai
Our HBeAg antibody in China has the largest market share, and most of Chinese manufacturers use our antibody. It has good specificity and high sensitivity, and even the relevant rate with Abbott reagent is over 99%,if you must use this product,please feel free to contact us!
|
anti-HBeAg is our most featured products, accounts for the largest market share in China |
Product information
HBeAg
Purity: >95%
Storage: cool or freezer as per COA instruction
Period of validity: as per COA instruction
Transportation: with cool pack
|
Catalogue No. |
Clone No. |
Recommendation (detector-capture) |
|
A0021 |
4F2 |
4F2-3A3 4F2-6E10 6E10-4F2 3A3-3C3/4F2 |
|
A0022 |
3A3 |
|
|
A0023 |
7B7 |
|
|
A0024 |
6E10 |
|
|
A0025 |
2B2 |
|
|
A0026 |
3C3 |
|
|
A0027 |
1D10 |
-
Aoke Botai Biotech , established in 2002, is a leading developer, manufacturer, and marketer of monoclonal antibodies and antigens for the In-Vitro Diagnostic (IVD) industry. As an ISO 13485:2016 and ISO 9001:2016 certified company, we maintain the highest standards of quality and operational excellence.
We take pride in being the pioneering organization in China to develop antibody pairs for HbeAg detection. Our extensive portfolio includes over 50 high-quality monoclonal antibody projects and more than 40 high-quality antigen projects, with this number continuously expanding year after year.
With a dedicated team of experienced researchers, a state-of-the-art 4,000-square-meter production facility, we are fully equipped to ensure both dependable quality and a consistent supply capacity.Our products have garnered recognition and approval across diverse applications, including tumor markers, cardiovascular health, inflammation, infectious diseases, hormone analysis, and kidney markers, where they have consistently demonstrated performance on par with esteemed international benchmark brands.
In 2021, we expanded our capabilities with the launch of the colloidal gold and fluorescent chromatography board production line to cater to global customer demands. We are committed to delivering excellence and aim to establish a world-class supply base for diagnostic reagent raw materials.
| Request Information |
| Related Products |
